iLobby 100m Partners Aisawersventurebeat

 iLobby, a visitor software provider, got $100 million in funding from Insight Partners. This was the first-ever round of funding for iLobby. iLobby plans to use these funds to gauge the go-to-market operations. They also plan to expand the product functionality. ilobby 100m partners aisawersventurebeat.

The impressive customer list of iLobby is across 45 countries and includes Netflix, Pepsi, Scotiabank, Toronto Pearson International Airport and Unilever. The revenue has grown consistently 100% YoY across many years since its inception in 2013. COVID-19 accelerated the demand for the product. ilobby 100m aisawersventurebeat.

iLobby has its headquarters in Toronto, Canada. Their core product is a SaaS visitor management platform. Integration of the platform can happen with access control, CRM, HR directories and file storage systems. It can leverage solutions to boost on-site security management by tracking visiting contractors. It works for guest registration, check-ins and analytics. ilobby insight partners aisawersventurebeat.

It gets equipped to design user interfaces, workflows and administrative controls. This allows it to optimize the visitor management process in high-security, tightly related environments. Airports, governmental buildings and finance offices can use them. ilobby 100m insight aisawersventurebeat.

The visitor management software market is doing well on a broader scale. There were many new product launches in the past 12 months. Proxyclick raised $15 million in a Series B funding round to expand its sales and product development prospects. Traction Guest unveiled a vaccine attestation registry module. This aims to support their clients to return to work at par with the safety procedures safely. ilobby aisawersventurebeat.

Such developments showcase visitor management software as a potent growth area. As per a 2020 survey, 56% of facility managers invest in visitor management solutions at one or more sites. Or they should replace the old systems that failed to meet the safety requirements of the COVID-19 pandemic.